Hypercholesterolemia Attenuates Angiogenesis but Does Not Preclude Augmentation by Angiogenic Cytokines
- 21 October 1997
- journal article
- research article
- Published by Wolters Kluwer Health in Circulation
- Vol. 96 (8) , 2667-2674
Abstract
Background The impact of hyperlipidemia on collateral vessel development in vivo remains enigmatic. We sought to determine the anatomic extent and functional capacity of the collateral bed that develops in response to limb ischemia in a well characterized animal model of spontaneous hypercholesterolemia, the Watanabe heritable hyperlipidemic (WHHL) rabbit. We further characterized the impact of exogenous angiogenic cytokine administration on collateral vessel development and function in the same animal model. Methods and Results Weight-matched 6-month-old male homozygous WHHL (n=9) and normal New Zealand White (NZW) (n=9) rabbits underwent surgical resection of one femoral artery. Ten days later, the ischemic hindlimb was evaluated for collateral vessel formation, blood flow, and tissue damage. Collateral vasculature was less extensive among WHHL than NZW, as indicated by a significant reduction in angiographic score (0.19±0.02 versus 0.35±0.03, P <.001) and capillary density (46.4±4.1 versus 78.9±4.6/mm 2 , P <.0002). This was associated with a reduction in calf blood pressure index (9.5±3.5% versus 32.8±2.8%, P <.0001), arterial blood flow (7.5±0.6 versus 13.6±0.7 mL/min, P <.0001), and muscle perfusion index (40.1±3.2% versus 65.9±2.0%, P <.0001) and an increase in muscle necrosis (48.16±5.41% versus 25.90±3.83% negative 2,3,5-triphenyltetrazolium chloride staining, P <.004). Treatment of WHHL rabbits (n=9) with recombinant human vascular endothelial growth factor produced a statistically significant improvement in all functional as well as anatomic indices of collateral development. Conclusions Collateral vessel development associated with hindlimb ischemia in vivo is severely attenuated in an animal model of spontaneous hypercholesterolemia but nevertheless may be augmented by administration of angiogenic cytokines.Keywords
This publication has 15 references indexed in Scilit:
- Patterns and Emerging Mechanisms of the Angiogenic Switch during TumorigenesisCell, 1996
- Role of lysophosphatidylcholine in the inhibition of endothelial cell motility by oxidized low density lipoprotein.Journal of Clinical Investigation, 1996
- Hypoxia Induces Vascular Endothelial Growth Factor in Cultured Human Endothelial CellsJournal of Biological Chemistry, 1995
- Basic fibroblast growth factor reverses atherosclerotic impairment of human coronary angiogenesis-like responses in vitroAtherosclerosis, 1995
- Therapeutic angiogenesis. A single intraarterial bolus of vascular endothelial growth factor augments revascularization in a rabbit ischemic hind limb model.Journal of Clinical Investigation, 1994
- Mechanisms of AngiogenesisAnnual Review of Physiology, 1987
- Impaired muscarinic endothelium-dependent relaxation and cyclic guanosine 5'-monophosphate formation in atherosclerotic human coronary artery and rabbit aorta.Journal of Clinical Investigation, 1987
- The effect of long-term vasodilatation on capillary growth and performance in rabbit heart and skeletal muscleCardiovascular Research, 1984
- WHHL‐Rabbit: a low density lipoprotein receptor‐deficient animal model for familial hypercholesterolemiaFEBS Letters, 1980
- Serial inbreeding of rabbits with hereditary hyperlipidemia (WHHL-rabbit) *1Incidence and development of atherosclerosis and xanthomaAtherosclerosis, 1980